NeOnc Technologies and CBCC Global Research Collaborate to Advance Neuro-Oncology Treatments
Westlake Village, CA – NeOnc Technologies Holdings, Inc. (NTHI), a pioneering clinical-stage medical biotechnology company, recently announced a strategic partnership with CBCC Global Research (CBCC), a leading full-service clinical research organization (CRO). This collaboration aims to expand NeOnc’s clinical trial capabilities in India, paving the way for the development and advancement of NeOnc’s neuro-oncology treatment.
About NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a medical biotechnology company based in Westlake Village, California. With a focus on clinical-stage research, NeOnc is dedicated to developing innovative treatments for neuro-oncology, a field that addresses various neurological disorders, including brain tumors and neurodegenerative diseases.
About CBCC Global Research
CBCC Global Research is a renowned clinical research organization headquartered in Hyderabad, India. With over 20 years of experience in the industry, CBCC offers a range of services, including clinical trial management, data management, biostatistics, regulatory affairs, and medical writing. The organization has successfully executed over 500 clinical trials in various therapeutic areas.
The Strategic Partnership
The strategic partnership between NeOnc and CBCC will enable NeOnc to leverage CBCC’s extensive expertise and resources in clinical research. CBCC’s local knowledge and established infrastructure in India will facilitate NeOnc’s clinical trial initiatives, ensuring a smoother and more efficient process. This collaboration is a significant step forward in NeOnc’s mission to develop and bring neuro-oncology treatments to the market.
Impact on Individuals
For individuals diagnosed with neurological disorders, this partnership brings hope for the development of innovative treatments. NeOnc’s dedication to neuro-oncology research, combined with CBCC’s clinical trial expertise, could lead to groundbreaking discoveries and improved treatment options.
Impact on the World
The collaboration between NeOnc and CBCC has the potential to make a significant impact on the global healthcare landscape. With the increasing prevalence of neurological disorders worldwide, the need for advanced treatments is more pressing than ever. This partnership could pave the way for the development of new, effective neuro-oncology treatments, ultimately improving the quality of life for millions of people around the world.
Conclusion
NeOnc Technologies Holdings, Inc.’s strategic partnership with CBCC Global Research marks an important milestone in the advancement of neuro-oncology treatments. With CBCC’s clinical trial expertise and NeOnc’s dedication to research, the collaboration is poised to bring about groundbreaking discoveries and improved treatment options for neurological disorders. This partnership not only holds significance for individuals diagnosed with these conditions but also for the global healthcare community as a whole.
References
- NeOnc Technologies Holdings, Inc. (2025, March 27). NeOnc Technologies Holdings, Inc. Announces Strategic Partnership with CBCC Global Research to Expand Clinical Trial Capabilities in India. GlobeNewswire.
- CBCC Global Research (n.d.). About Us. Retrieved from
- Neuro-Oncology (n.d.). National Institute of Neurological Disorders and Stroke. Retrieved from
